Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Cartesian Therapeutics has raised $50.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
Cartesian Therapeutics's investors include Invus, K2 HealthVentures, Surveyor Capital, HBM Healthcare Investments, Schooner Capital.
Cartesian Therapeutics is headquartered in Gaithersburg, United States.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Cartesian Therapeutics is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cartesian Therapeutics — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/cartesian-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Cartesian Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cartesian-therapeutics
{{cite web |title=Cartesian Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cartesian-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated